Hardy Alexander
Insider CIK 2001910 · BMRN Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2026-03-17 | 2026-03-19 | 4,252 | $56.05 | $238.3K | 214,635 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2026-03-16 | 2026-03-17 | 89,200 | — | $0 | 89,200 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-03-16 | 2026-03-17 | 62,440 | — | $0 | 218,887 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2026-03-13 | 2026-03-17 | 2,941 | $58.51 | $172.1K | 156,447 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2025-12-01 | 2025-12-02 | 16,570 | $55.03 | $911.8K | 159,388 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-04-30 | 2025-12-02 | 375 | $54.14 | $20.3K | 175,958 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2025-03-17 | 2025-03-18 | 61,750 | — | $0 | 61,750 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-03-17 | 2025-03-18 | 44,360 | — | $0 | 175,583 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2025-03-14 | 2025-03-18 | 2,933 | $69.44 | $203.7K | 131,223 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-11-29 | 2024-12-03 | 14,295 | $66.03 | $943.9K | 134,156 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-10-31 | 2024-12-03 | 300 | $56.01 | $16.8K | 148,451 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2024-03-15 | 2024-03-19 | 44,050 | — | $0 | 44,050 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-03-15 | 2024-03-19 | 32,780 | — | $0 | 148,151 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2023-12-01 | 2023-12-05 | 150,529 | — | $0 | 150,529 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-12-01 | 2023-12-05 | 47,332 | — | $0 | 115,371 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-12-01 | 2023-12-05 | 68,039 | — | $0 | 68,039 | SEC↗ |